New perspectives for gene therapy in endocrinology

被引:16
作者
Barzon, L
Bonaguro, R
Palù, G
Boscaro, M
机构
[1] Univ Padua, Dept Med & Surg Sci, I-35128 Padua, Italy
[2] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy
关键词
D O I
10.1530/eje.0.1430447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene therapy for endocrine diseases represents an exciting new type of molecular intervention that may be a curative one. Endocrine disorders that might be treated by gene therapy include monogenic diseases, such as GH deficiency and hypothalamic diabetes insipidus, and multifactorial diseases, such as diabetes mellitus, obesity and cancer. Premises seem promising for endocrine tumours, but many combined approaches of cell and gene therapy are foreseeable also for other endocrine disorders. This review outlines the principles of gene therapy, describes the endocrine disorders that might take advantage of gene transfer approaches, as well as the gene therapy interventions that have already been attempted, their major limitations and the problems that remain to be solved.
引用
收藏
页码:447 / 466
页数:20
相关论文
共 209 条
  • [51] PITUITARY FOLLICULAR CELLS PRODUCE BASIC FIBROBLAST GROWTH-FACTOR
    FERRARA, N
    SCHWEIGERER, L
    NEUFELD, G
    MITCHELL, R
    GOSPODAROWICZ, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) : 5773 - 5777
  • [52] DOMINANT INTERFERING FAS GENE-MUTATIONS IMPAIR APOPTOSIS IN A HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
    FISHER, GH
    ROSENBERG, FJ
    STRAUS, SE
    DALE, JK
    MIDDELTON, LA
    LIN, AY
    STROBER, W
    LENARDO, MJ
    PUCK, JM
    [J]. CELL, 1995, 81 (06) : 935 - 946
  • [53] Fontanini G, 1996, MODERN PATHOL, V9, P636
  • [54] Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release
    Freese, A
    During, MJ
    Davidson, BL
    Gennarelli, TA
    Kaplitt, MG
    Flamm, ES
    Snyder, PJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) : 2401 - 2404
  • [55] Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
    French, MB
    Allison, J
    Cram, DS
    Thomas, HE
    DempseyCollier, M
    Silva, A
    Georgiou, HM
    Kay, TW
    Harrison, LC
    Lew, AM
    [J]. DIABETES, 1997, 46 (01) : 34 - 39
  • [56] Transfection of an inducible p16/CDKN2A construct mediates reversible growth inhibition and G1 arrest in the AtT20 pituitary tumor cell line
    Frost, SJ
    Simpson, DJ
    Clayton, RN
    Farrell, WE
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (11) : 1801 - 1810
  • [57] Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival
    Gainer, AL
    Korbutt, GS
    Rajotte, RV
    Warnock, GL
    Elliott, JF
    [J]. TRANSPLANTATION, 1997, 63 (07) : 1017 - 1021
  • [58] Gallichan WS, 1999, J IMMUNOL, V163, P1696
  • [59] Long-term gene therapy in the CNS: Reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin
    Geddes, BJ
    Harding, TC
    Lightman, SL
    Uney, JB
    [J]. NATURE MEDICINE, 1997, 3 (12) : 1402 - 1404
  • [60] Persistent transgene expression in the hypothalamus following stereotaxic delivery of a recombinant adenovirus: Suppression of the immune response with cyclosporin
    Geddes, BJ
    Harding, TC
    Hughes, DS
    Byrnes, AP
    Lightman, SL
    Conde, G
    Uney, JB
    [J]. ENDOCRINOLOGY, 1996, 137 (11) : 5166 - 5169